title: QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
authors.forename: Konstantinos P
authors.initials: KP
authors.lastname: Letsas
authors.forename: Gerasimos S
authors.initials: GS
authors.lastname: Filippatos
authors.forename: Stavros P
authors.initials: SP
authors.lastname: Kounas
authors.forename: Michalis
authors.initials: M
authors.lastname: Efremidis
authors.forename: Antonios
authors.initials: A
authors.lastname: Sideris
authors.forename: Fotis
authors.initials: F
authors.lastname: Kardaras
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D004347:Drug Interactions; D004554:Electric Countershock; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000628:therapy; D011725:Pyridines / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000628:therapy; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000628:therapy; D000077334:Zolpidem
chemical_list: D000889:Anti-Arrhythmia Agents; D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem; D000638:Amiodarone